Further, the data from FCM detection suggested expression of IL36 was higher in CD4+ T cells than in CD8+ T cells, and was the highest in HCC patients compared with hepatitis patients and healthy controls, this highlighted that IL36 was probably mainly from the CD4+ T cells of PBMC. The gene discussed is CD4; the disease is hepatocellular carcinoma.